Pharmacelera
3 known investors
Pharmacelera develops computational chemistry software and services for drug discovery, using proprietary 3D molecular field descriptors, quantum mechanics, and AI to screen ultra-large chemical libraries and identify novel, synthesizable compounds. It serves small biotech companies, big pharma R&D departments, public research institutions, and CROs across stages from target identification to lead optimization.
AI & Machine LearningBiotechDeep Tech
Investors Β· 3
Frequently asked questions
- What does Pharmacelera do?
- Pharmacelera develops computational chemistry software and services for drug discovery, using proprietary 3D molecular field descriptors, quantum mechanics, and AI to screen ultra-large chemical libraries and identify novel, synthesizable compounds. It serves small biotech companies, big pharma R&D departments, public research institutions, and CROs across stages from target identification to lead optimization.
- Who are Pharmacelera's investors?
- Pharmacelera's investors include Capital Cell, GENERAL INCEPTION, Heran Partners.